Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
20.69
+0.20 (0.98%)
Jun 11, 2026, 4:00 PM EDT - Market closed
Evommune Revenue
Evommune had revenue of $10.00M in the twelve months ending March 31, 2026, up 233.33% year-over-year. In the year 2025, Evommune had annual revenue of $13.00M with 85.71% growth.
Revenue (ttm)
$10.00M
Revenue Growth
+233.33%
P/S Ratio
74.52
Revenue / Employee
$208,333
Employees
48
Market Cap
745.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.00M | 6.00M | 85.71% |
| Dec 31, 2024 | 7.00M | 2.00M | 40.00% |
| Dec 31, 2023 | 5.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionEVMN News
- 9 days ago - Evommune Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Evommune price target raised to $55 from $54 at Morgan Stanley - TheFly
- 5 weeks ago - Evommune reports Q1 EPS (64c), consensus (71c) - TheFly
- 5 weeks ago - Evommune Reports First Quarter 2026 Financial Results and Provides Business Highlights - Business Wire
- 5 weeks ago - Evommune Quarterly report: Q1 2026 - Filings
- 5 weeks ago - Evommune Earnings release: Q1 2026 - Filings
- 5 weeks ago - Evommune Slides: Corporate presentation - Filings
- 6 weeks ago - Evommune initiated with a Buy at Stifel - TheFly